Results 131 to 140 of about 61,573 (234)

Actividad de ceftolozano-tazobactam en aislados clínicos de Pseudomonas aeruginosa multirresistente y extremadamente resistente en un hospital español [PDF]

open access: yes, 2019
Objetivos: Nuestro objetivo fue evaluar la sensibilidad in vitro de ceftolozano-tazobactam en aislados clínicos de P. aeruginosa multirresistente (MDR) y extremadamente resistente (XDR) desde Febrero de 2016 a Octubre de 2017 en el Hospital Universitario
Morilla Morales, Elena   +8 more
core  

Low‐Titre ANA Late‐Onset Systemic Lupus Erythematosus Presenting With Pleural Effusion and Markedly Elevated Pleural Adenosine Deaminase Mimicking Tuberculous Pleuritis

open access: yesRespirology Case Reports, Volume 14, Issue 11, November 2026.
Pleural effusion with markedly elevated adenosine deaminase levels usually suggests tuberculous pleuritis. We report a case of low‐titre ANA late‐onset systemic lupus erythematosus presenting with lymphocyte‐predominant pleural effusion and markedly elevated ADA levels mimicking tuberculosis.
Shigesato Inoue   +5 more
wiley   +1 more source

Pinhole‐Like Central Bronchial Narrowing: A Rare Reversible Manifestation of Eosinophilic Bronchial Inflammation

open access: yesRespirology Case Reports, Volume 14, Issue 11, November 2026.
Eosinophilic bronchial inflammation can cause severe central bronchial narrowing and recurrent atelectasis, even in patients with well‐controlled asthma. Endobronchial biopsy can establish the diagnosis and identify this potentially reversible, corticosteroid‐responsive condition.
Ryusuke Kizawa   +7 more
wiley   +1 more source

Microbiological Quality and Analysis of Escherichia coli Resistance to Antibiotics in Beaches: Evaluating Anthropic Influence in Surface Waters in Brazil

open access: yesWater Environment Research, Volume 98, Issue 11, November 2026.
Anthropic activities and untreated wastewater promote the dissemination of antibiotic‐resistant E. coli (83.3% of isolates) in coastal waters, increasing environmental contamination and public health risks. ABSTRACT Antimicrobial resistance is a problem for public health.
Monica M. Elias   +8 more
wiley   +1 more source

Pronounced Reductions in Plasma Citrulline Indicate Severe Intestinal Mucosal Barrier Injury During Induction Therapy for Pediatric Acute Myeloid Leukemia

open access: yesEuropean Journal of Haematology, Volume 117, Issue 5, Page 1275-1284, November 2026.
ABSTRACT Objectives Pediatric acute myeloid leukemia (AML) chemotherapy regimens are frequently burdened by fever episodes, systemic inflammation and bloodstream infections (BSI). Mucosal barrier injury may contribute to these complications, but its role in childhood AML remains uninvestigated.
Carla Warley Kjær   +8 more
wiley   +1 more source

Antimicrobial Resistance in Periodontal Disease: Rethinking Adjunctive Therapy in the Metagenomics Era, the Pressing Need for Precision Treatment and Periodontal Resistome Mapping

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 21, November 2026.
ABSTRACT Systemic antibiotics are effective when used as adjunctive therapy in the treatment of periodontitis; however, their use must be balanced against antimicrobial resistance, which is a major threat to global public health. This review provides an expert synthesis of the literature and a field‐level overview of antimicrobial resistance in ...
Meera Alghafri   +3 more
wiley   +1 more source

SUSCEPTIBILITIES OF ESBL-PRODUCING ENTEROBACTERIAECEAE TO ERTAPENEM, MEROPENEM AND PIPERACILLIN-TAZOBACTAM

open access: yesNational Journal of Medical Research, 2012
Objectives: The susceptibilities of ESBL-producing E.coli and K. pneumoniae to ertapenem, meropenem and piperacillin-tazobactam.53 strains of E.coli and K. pneumoniae were studied.  Methods: They were originally resistant to ceftazidine.
Kinal Shah , Summaya A Mulla
doaj  

Keeping the horse with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales?

open access: yes
Ceftolozane/tazobactam is widely used against extended-spectrum β-lactamase (ESBL)-producing Enterobacterales, yet FDA-approved dosing relies on intermittent infusion and a fixed 2:1 ratio that assumes adequate β-lactamase inhibition. Tazobactam’s faster
Gatti, Milo   +7 more
core   +1 more source

Population pharmacokinetics of piperacillin/tazobactam in critically ill pediatric patients. [PDF]

open access: yesAntimicrob Agents Chemother
Dorofaeff T   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy